Family Medicine · Evansville, IN
NPI
1407205958
Since 2016
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
801 Felstead Rd
Evansville, IN, 47712
Phone (812) 490-3880
Groups this clinician bills Medicare through
Medicare paid, 2024
$113K
1,926 services
Medicare patients, 2024
272
Average age 74
Drug cost, 2024
$520K
7,958 prescriptions
Company payments, 2025
$992
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Anna Fehrenbacher was code 99213 (office e&m - established), 382 times for 205 patients. In total Anna Fehrenbacher billed 1,926 services in 74 codes, and Medicare paid $113K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-10-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 382 | 205 | $51.78 | $20K |
| 99214 Office E&M - Established | Office | 315 | 184 | $82.50 | $26K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 204 | 204 | $120.33 | $25K |
| G0008 Administration of influenza virus vaccine | Office | 67 | 65 | $30.10 | $2,017 |
| 90662 Vaccine Product | Office | 56 | 56 | $81.82 | $4,582 |
| 90480 Vaccine Administration | Office | 55 | 54 | $40.06 | $2,203 |
| 91320 Vaccine Product | Office | 54 | 53 | $148.28 | $8,007 |
| 96372 Injection Administration | Office | 43 | 13 | $10.04 | $432 |
| G0009 Administration of pneumococcal vaccine | Office | 16 | 16 | $30.10 | $482 |
| 90677 Vaccine Product | Office | 15 | 15 | $290.24 | $4,354 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 14 | 14 | $12.23 | $171 |
| 87637 Infectious Agent Detection by DNA/RNA | Office | 12 | 12 | $139.78 | $1,677 |
| G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 11 | 11 | $153.98 | $1,694 |
By year: 2022 $105K for 1,885 services; 2023 $114K for 1,828 services; 2024 $113K for 1,926 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 87637 Infectious Agent Detection by DNA/RNA | 12 | 12 | $139.78 | $1,677 |
Medicare prescription drug claims, 2024
In 2024, the drug Anna Fehrenbacher prescribed most often to Medicare patients was Atorvastatin Calcium, with 505 prescriptions and refills. In total Anna Fehrenbacher wrote 7,958 Medicare prescriptions that cost $520K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 505 | 1,425 | 133 | $2,713 |
| Amlodipine Besylate Generic | 366 | 1,040 | 104 | $1,771 |
| Levothyroxine Sodium Generic | 351 | 944 | 79 | $2,191 |
| Lisinopril Generic | 331 | 928 | 94 | $1,256 |
| Montelukast Sodium Generic | 227 | 540 | 67 | $2,497 |
| Omeprazole Generic | 216 | 588 | 60 | $1,904 |
| Losartan Potassium Generic | 186 | 503 | 52 | $1,011 |
| Metoprolol Succinate Generic | 174 | 459 | 44 | $2,166 |
| Furosemide Generic | 150 | 331 | 45 | $647 |
| Simvastatin Generic | 141 | 403 | 38 | $671 |
| Rosuvastatin Calcium Generic | 136 | 401 | 37 | $1,105 |
| Gabapentin Generic | 134 | 234 | 34 | $2,017 |
| Trazodone Hcl Generic | 124 | 256 | 29 | $739 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 123 | 137 | 52 | $2,974 |
| Buspirone Hcl Generic | 121 | 273 | 32 | $1,085 |
Brand drugs: 662 claims; generic drugs: 7,271 claims; opioid claims: 120.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Anna Fehrenbacher $992 ($992 in general payments such as food, travel and fees) from 18 companies. The largest payer was Abbvie Inc. with $262.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 23 | $262 |
| Pfizer Inc. PFE | 8 | $143 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) JNJ | 4 | $93.35 |
| Axsome Therapeutics, Inc. AXSM | 4 | $77.19 |
| Novo Nordisk Inc NVO | 5 | $75.68 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 3 | $64.61 |
| Corium, LLC | 5 | $62.33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 2 | $38.13 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $30.34 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $28.65 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.